- Home
- HCM vs JPC Comparison
HCM vs JPC Comparison
Compare HCM & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- JPC
- Stock Information
- Founded
- HCM 2000
- JPC 2003
- Country
- HCM Hong Kong
- JPC United States
- Employees
- HCM N/A
- JPC N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- JPC Investment Managers
- Sector
- HCM Health Care
- JPC Finance
- Exchange
- HCM Nasdaq
- JPC Nasdaq
- Market Cap
- HCM 2.5B
- JPC 2.5B
- IPO Year
- HCM N/A
- JPC N/A
- Fundamental
- Price
- HCM $15.92
- JPC $8.12
- Analyst Decision
- HCM Strong Buy
- JPC
- Analyst Count
- HCM 1
- JPC 0
- Target Price
- HCM $28.00
- JPC N/A
- AVG Volume (30 Days)
- HCM 44.4K
- JPC 998.5K
- Earning Date
- HCM 08-07-2025
- JPC 01-01-0001
- Dividend Yield
- HCM N/A
- JPC 7.57%
- EPS Growth
- HCM N/A
- JPC N/A
- EPS
- HCM 0.53
- JPC N/A
- Revenue
- HCM $602,197,000.00
- JPC N/A
- Revenue This Year
- HCM $15.00
- JPC N/A
- Revenue Next Year
- HCM $19.91
- JPC N/A
- P/E Ratio
- HCM $5.55
- JPC N/A
- Revenue Growth
- HCM N/A
- JPC N/A
- 52 Week Low
- HCM $11.51
- JPC $5.94
- 52 Week High
- HCM $21.50
- JPC $7.36
- Technical
- Relative Strength Index (RSI)
- HCM 43.91
- JPC 61.29
- Support Level
- HCM $14.64
- JPC $8.05
- Resistance Level
- HCM $16.17
- JPC $8.13
- Average True Range (ATR)
- HCM 0.50
- JPC 0.03
- MACD
- HCM -0.31
- JPC 0.00
- Stochastic Oscillator
- HCM 24.90
- JPC 80.00
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About JPC Nuveen Preferred & Income Opportunities Fund
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.